BioMarin Pharmaceutical, Inc. (BMRN)
58.51
+1.02
(+1.77%)
USD |
NASDAQ |
Oct 30, 16:00
58.54
+0.02
(+0.04%)
Pre-Market: 20:00
BioMarin Pharmaceutical 30-Day Average Daily Volume : 2.343M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 2.343M |
| October 29, 2026 | 2.415M |
| October 28, 2026 | 2.374M |
| October 27, 2026 | 2.383M |
| October 26, 2026 | 2.362M |
| October 23, 2026 | 2.328M |
| October 22, 2026 | 2.326M |
| October 21, 2026 | 2.319M |
| October 20, 2026 | 2.301M |
| October 19, 2026 | 2.233M |
| October 16, 2026 | 2.210M |
| October 15, 2026 | 2.172M |
| October 14, 2026 | 2.158M |
| October 13, 2026 | 2.156M |
| October 12, 2026 | 2.144M |
| October 09, 2026 | 2.102M |
| October 08, 2026 | 2.072M |
| October 07, 2026 | 2.031M |
| October 06, 2026 | 2.007M |
| October 05, 2026 | 1.959M |
| October 02, 2026 | 1.932M |
| October 01, 2026 | 1.901M |
| September 30, 2026 | 1.898M |
| September 29, 2026 | 1.903M |
| September 28, 2026 | 1.917M |
| Date | Value |
|---|---|
| September 25, 2026 | 1.885M |
| September 24, 2026 | 1.903M |
| September 23, 2026 | 1.942M |
| September 22, 2026 | 2.004M |
| September 21, 2026 | 2.107M |
| September 18, 2026 | 2.190M |
| September 17, 2026 | 2.156M |
| September 16, 2026 | 2.166M |
| September 15, 2026 | 2.133M |
| September 14, 2026 | 2.132M |
| September 11, 2026 | 2.167M |
| September 10, 2026 | 2.154M |
| September 09, 2026 | 2.141M |
| September 08, 2026 | 2.141M |
| September 04, 2026 | 2.147M |
| September 03, 2026 | 2.135M |
| September 02, 2026 | 2.169M |
| September 01, 2026 | 2.132M |
| August 31, 2026 | 2.127M |
| August 28, 2026 | 2.090M |
| August 27, 2026 | 2.107M |
| August 26, 2026 | 2.108M |
| August 25, 2026 | 2.076M |
| August 24, 2026 | 2.077M |
| August 21, 2026 | 2.054M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Exelixis, Inc. | 2.250M |
| Ascendis Pharma A/S | 731224.8 |
| Alnylam Pharmaceuticals, Inc. | 1.861M |
| Anika Therapeutics, Inc. | 102338.5 |
| Cytokinetics, Inc. | 1.850M |